BSC
RVMD icon

BOLTON SECURITIES CORPORATION’s Revolution Medicines RVMD Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$217K Buy
1,059
+563
+114% +$112K 0.01% 866
2026
Q2 		$92.9K Buy
+496
New +$72.4K ﹤0.01% 1137
2025
Q1 		$212K Buy
+6,000
New +$244K 0.01% 681

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's RVMD Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION increased its Revolution Medicines (RVMD) stake by 114% in Q3 2026, buying an estimated $112K and bringing the position to 1,059 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #866.

BOLTON SECURITIES CORPORATION first reported a position in RVMD in Q1 2025 and has held it in 3 quarters since. 471 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 1,059 shares of Revolution Medicines worth $217K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION bought 563 Revolution Medicines shares in Q3 2026, an estimated $112K.
  • Revolution Medicines made up 0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #866 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Revolution Medicines in Q1 2025 and has held it in 3 quarters since.
  • 471 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.